Cell-based cancer treatments such as NK Cell Therapy are an excellent alternative to traditionally dangerous, high-dose chemotherapy or radiation therapies used by oncologists around the world. CD4+ T-Lymphocyte Cell Regeneration to treat non-Hodgkin lymphoma may be the solution.
Immunotherapy – Treat Cancer without Chemo
CAR T-cell therapy
Our immune system constantly works to identify and monitor all bodily substances, ensuring that anything foreign or harmful, such as bacteria, viruses, or mutated cells, is promptly dealt with. When a new, unfamiliar substance is detected, it triggers an immune response, raising an internal alarm that signals the body to attack and eliminate the invader. However, cancer cells can sometimes evade this natural defense mechanism by mimicking normal cells or creating an environment that suppresses immune responses, allowing them to grow unchecked.
Chimeric antigen receptor (CAR) T-cell therapy represents a major advancement in cancer treatment by enhancing the body’s ability to recognize and attack cancer cells. This innovative therapy involves extracting a patient’s T cells, a type of white blood cell that plays a crucial role in immune defense, and genetically modifying them in a laboratory to recognize cancer cells better. The modification process equips the T cells with a synthetic receptor known as a chimeric antigen receptor (CAR), specifically designed to target proteins on the surface of cancer cells. Once reprogrammed, the enhanced T cells are multiplied and reintroduced into the patient’s bloodstream.
These modified T cells, now equipped with the CAR, can actively seek out cancer cells throughout the body, binding to them and initiating a potent immune attack that destroys the malignant cells. Unlike traditional cancer treatments such as chemotherapy or radiation, which can also harm healthy tissues, CAR T-cell therapy is highly targeted, focusing specifically on cancer cells. This precision reduces collateral damage to normal cells and increases the effectiveness of the treatment.
Moreover, CAR T-cell therapy is a form of cell-based gene therapy because it alters the genetic makeup of the patient’s immune cells. By reprogramming these cells, the therapy can harness the immune system’s power to fight cancer in a more efficient and enduring way. In some cases, these modified T cells can remain in the body long after the initial treatment, providing continued protection against cancer recurrence. As a result, CAR T-cell therapy holds significant promise for patients with certain types of cancer, especially those who have been resistant to conventional treatments. However, the therapy is not without risks, including potential side effects such as cytokine release syndrome and neurotoxicity, which require careful monitoring and management during treatment.
Stem Cells & Treating Cancer
Stem cells can and are being used to treat cancer today. Gene Therapies, senolytic therapies, and stem cell-based cancer treatments are used throughout the world but for only a few types of diseases, such as non-Hodgkins lymphoma. Stem cells can treat the two main types of blood cancers, lymphoma and leukemia when children or adults are given a high dosage of chemotherapy to try to irradiate as many cancer cells as possible, which it does but at the high cost of massive destruction of bone marrow 
that produces stem cells that are needed by the body to recover and regenerate. To overcome this obstacle, oncologists have been using injections of umbilical cord blood or placenta-derived stem cells from otherwise healthy donors to allow the body to recover as it naturally should have the bone marrow still viable. These implanted stem cells are usually injected into the patient’s veins, similar to blood transfusions. Once the enhanced cells are introduced via engraftment into the body, they return to the patient’s bone marrow and quickly produce healthy hematopoietic blood cells. This process is not recommended for everyone and may cause other complications for patients with late stages or other underlying diseases that will affect cell therapy for cancer. Is cancer considered an autoimmune disease?
TREATMENT RISKS & PRECAUTIONS
Please note that not all patients are suitable candidates for treating Cancer, immunotherapy, or targeted therapies. Patients with advanced metastatic disease, significant multi-organ involvement, or other major health complications might not be good candidates for the estimated 3-5 week treatment.Candidates for Lymphocyte Restoration
Ideal candidates for our cancer treatment protocol are:
- Your Non-Hodgkins lymphoma or Relapsed Hodgkin’s disease
- Relapsed or high-risk non-Hodgkin’s lymphoma
- large B-cell lymphoma is likely to come back
- Non-responsive cancer/lymphoma
- Relapsed testicular cancer
- Modified Immunotherapy for Lung Cancer
- Multiple myelomas
- Treatment for Liver cancer
- Acute leukemia
- Colorectal cancer (CRC)
- Treatment for Prostate cancer
- Treatment of pancreatic cancer
Modified Immune Cells to Fight Cancer – 2024
The Two Types of Cells Used in Cancer Remediation:
- Autologous stem cells for cancer come from your own body. Usually via Peripheral Blood stem cells, Bone marrow stem cells, dental pulp stem cells, and adipose fat stem cells.
- Allogeneic stem cells for cancer come from blood-matched or family donors. (Not from your own body) Allogeneic stem cell transplants are most commonly used to treat certain types of cancers, lymphomas, and leukemia, along with bone marrow disorders line myelodysplasia. [1]
Safe, Targeted, & Individualized for Better Success Rates
Stem Cell Collection and Expansion
Your specific protocol will depend on your current diagnosed needs. Typically, stem cell treatments for cancer require a multidisciplinary approach to ensure our clients can make a complete recovery and continue to live long and healthy lives.
Depending on your needs, we offer a few solutions to treat cancers with and without the need for just Chemotherapy, including:
- Radiotherapy Treatment using High Intensity Focused Ultrasound – HIFU
- Lymphocyte Regeneration using Hematopoietic stem cells [2]
- Combination of both plus other treatments such as Monoclonal antibody therapy and steroids
- Proton Beam Therapy
High-dose Stem Cell Transplants
The Regeneration Center offers a unique cancer treatment that requires cell collection for 2 or 3 days to ensure our doctors can collect enough of the needed types of cells. Collecting the stem cells requires 1 to 3 hours each visit.
The collection requires no surgery or anesthesia and is generally non-invasive [3]. If your blood work and cell counting (flow cytometer) don’t show enough quantities of the needed types of stem cells, you may need injections of G-CSF to promote your bone marrow (iliac crest extractions) to release more stem cells. We also offer stem cell banking for up to 25 years if you want to save your stem cells as an insurance policy for traumatic events such as brain strokes & heart attacks.[4]
enlargement
Cancer Immunotherapy Program Costs in 2024
All cancer treatment protocols require a minimum of 14-30 nights in Bangkok. Due to the varying degrees/stages of Illness, our medical team and oncologist will need to better understand the potential patient’s condition before acceptance into the program.
To determine eligibility for treatment and get therapy recommendations with fixed-cost treatment plans, our medical team will need to better understand the patient’s existing needs via recent histological results, Biopsies, DNA Tests, blood tests, x-rays, scans, bone marrow sample results, or clinical diagnosis from your oncologist in your home country.
Upon acceptance, specifics relating to the treatment will be provided, including the total number of nights required and the medical-related costs (excluding accommodations or flights). The exact prices for the stem cell cancer protocol will include all the hospital fees, stem cell extraction and expansion fees, doctor fees, and follow-up consultations for 12 months after treatment.
To learn more or apply to our alternative treatment for cancer without Chemotherapy, please contact us Today.
Published Clinical Citations
[1] ^ Kheansaard, Wasinee, Sumana Mas-Oo-di, Surasak Nilganuwong, and Dalina I Tanyong. 2012. Interferon-gamma induced nitric oxide-mediated apoptosis of anemia of chronic disease in rheumatoid arthritis. Rheumatology international, no. 1 (January 19). doi:10.1007/s00296-011-2307-y. https://www.ncbi.nlm.nih.gov/pubmed/22258456
[2] ^ Sadler, Nicole M, Britney R Harris, Brittany A Metzger, and Julia Kirshner. 2013. N-cadherin impedes proliferation of the multiple myeloma cancer stem cells. American journal of blood research, no. 4 (December 18). https://www.ncbi.nlm.nih.gov/pubmed/24396705
[3] ^ Snyder, Joshua C, Lauren K Rochelle, Larry S Barak, and Marc G Caron. 2013. The stem cell-expressed receptor Lgr5 possesses canonical and functionally active molecular determinants critical to β-arrestin-2 recruitment. PloS one, no. 12 (December 27). doi:10.1371/journal.pone.0084476. https://www.ncbi.nlm.nih.gov/pubmed/24386388
[4] ^ Subbiah, Vivek, Robert E Brown, Mary F McGuire, Jamie Buryanek, Filip Janku, Anas Younes, and David Hong. 2014. A novel immunomodulatory molecularly targeted strategy for refractory Hodgkin’s lymphoma. Oncotarget, no. 1 ( 15). https://www.ncbi.nlm.nih.gov/pubmed/24395633